Welcome to LookChem.com Sign In|Join Free
  • or
(-)-2,3-O-Isopropylidene-D-threitol is a chiral compound derived from D-threitol, a sugar alcohol. It features a protected hydroxyl group through the formation of an isopropylidene moiety, which is crucial for its reactivity and stability in various chemical reactions.

73346-74-4

Post Buying Request

73346-74-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

73346-74-4 Usage

Uses

Used in Pharmaceutical Industry:
(-)-2,3-O-Isopropylidene-D-threitol is used as an intermediate in the synthesis of optically active enantiomorphic 2,3-butanediols. These enantiomers are essential in the development of chiral drugs, as they can exhibit different biological activities and selectivity.
Used in Organic Synthesis:
(-)-2,3-O-Isopropylidene-D-threitol is used as a reactant in the synthesis of O2,O3-isopropylidene-O1,O4-bis-(toluene-4-sulfonyl)-D-threitol. (-)-2,3-O-Isopropylidene-D-threitol can be further utilized in the preparation of various organic compounds, including pharmaceuticals and specialty chemicals, due to its unique structural features and reactivity.

Check Digit Verification of cas no

The CAS Registry Mumber 73346-74-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,3,4 and 6 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 73346-74:
(7*7)+(6*3)+(5*3)+(4*4)+(3*6)+(2*7)+(1*4)=134
134 % 10 = 4
So 73346-74-4 is a valid CAS Registry Number.
InChI:InChI=1/C7H14O4/c1-7(2)10-5(3-8)6(4-9)11-7/h5-6,8-9H,3-4H2,1-2H3/t5-,6-/m1/s1

73346-74-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (I0375)  (-)-2,3-O-Isopropylidene-D-threitol  >98.0%(GC)

  • 73346-74-4

  • 1g

  • 649.00CNY

  • Detail
  • TCI America

  • (I0375)  (-)-2,3-O-Isopropylidene-D-threitol  >98.0%(GC)

  • 73346-74-4

  • 5g

  • 1,960.00CNY

  • Detail
  • Alfa Aesar

  • (B24134)  (-)-2,3-O-Isopropylidene-D-threitol, 98%   

  • 73346-74-4

  • 1g

  • 510.0CNY

  • Detail
  • Alfa Aesar

  • (B24134)  (-)-2,3-O-Isopropylidene-D-threitol, 98%   

  • 73346-74-4

  • 5g

  • 2038.0CNY

  • Detail
  • Aldrich

  • (241415)  (−)-2,3-O-Isopropylidene-D-threitol  99%

  • 73346-74-4

  • 241415-1G

  • 524.16CNY

  • Detail

73346-74-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (-)-2,3-<i>O</i>-Isopropylidene-<small>D</small>-threitol

1.2 Other means of identification

Product number -
Other names [(4R,5R)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]methanol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:73346-74-4 SDS

73346-74-4Synthetic route

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
With methanol; sodium tetrahydroborate100%
With lithium aluminium tetrahydride In diethyl ether at 0℃; for 1.25h;99%
With lithium aluminium tetrahydride In diethyl ether Reflux; Inert atmosphere;99%
(4S,5S)-diethyl 2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate
73346-73-3

(4S,5S)-diethyl 2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
With sodium tetrahydroborate; lithium chloride In tetrahydrofuran; ethanol at 20℃; for 14h;92%
With lithium aluminium tetrahydride84%
With lithium aluminium tetrahydride In diethyl ether for 16h; Heating;81%
diisopropyl (2S,3S)-2,3-O-isopropylidenetartrate
81327-47-1

diisopropyl (2S,3S)-2,3-O-isopropylidenetartrate

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃;90%
bis(1-methylethyl) (4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate

bis(1-methylethyl) (4S,5S)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
With lithium aluminium tetrahydride In tetrahydrofuran at 0 - 20℃; for 4h; Inert atmosphere;88%
D-2,3-isopropylidene tartaric acid
126581-14-4

D-2,3-isopropylidene tartaric acid

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol at 0 - 20℃; for 16h; Inert atmosphere;85%
With sodium tetrahydroborate In ethyl [2]alcohol82%
With lithium aluminium tetrahydride In tetrahydrofuran Heating;
diethyl (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate
59779-75-8

diethyl (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dicarboxylate

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
With lithium aluminium tetrahydride77.3%
3,4-di-O-isopropylidene-D-mannitol
3969-84-4

3,4-di-O-isopropylidene-D-mannitol

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
With lead(IV) acetate; nickel; ethyl acetate Hydrogenation;
With sodium tetrahydroborate; sodium periodate 1.) aq. acetone, 0 deg C, 2 h, 2.) O deg C, 1 h; Yield given. Multistep reaction;
With sodium tetrahydroborate; sodium periodate Yield given. Multistep reaction;
(4R)-3,4-(isopropylidenedioxy)tetrahydrofuran-2-ol
109715-58-4

(4R)-3,4-(isopropylidenedioxy)tetrahydrofuran-2-ol

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
With lithium aluminium tetrahydride
(4S,5S)-2,2-dimethyl-[1,3]dioxolane-4,5-dicarbaldehyde
5754-27-8, 85362-89-6, 122137-20-6, 146566-82-7

(4S,5S)-2,2-dimethyl-[1,3]dioxolane-4,5-dicarbaldehyde

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
With sodium tetrahydroborate In water; acetone at 15 - 20℃;
2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

/PBAAB002-2250/

/PBAAB002-2250/

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 91 percent / p-TsOH / Heating
2: 87 percent / LiAlH4 / diethyl ether
View Scheme
2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

resin bound-Si(iPr2)-O-(CH2)3CHO

resin bound-Si(iPr2)-O-(CH2)3CHO

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 100 percent / TsOH / cyclohexane; methanol / 52 - 54 °C
2: 82 percent / NaBH4 / ethanol / 2.5 h / 20 °C
View Scheme
mannitol triacetonide
3969-59-3

mannitol triacetonide

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 70percent aq. CH3COOH / 1.5 h / 40 °C
2: 1.) sodium periodate, 2.) NaBH4 / 1.) aq. acetone, 0 deg C, 2 h, 2.) O deg C, 1 h
View Scheme
(+)-1,2,3,4,5,6-tris-O-isopropylidene-D-mannitol
3969-59-3, 4239-88-7, 81704-51-0

(+)-1,2,3,4,5,6-tris-O-isopropylidene-D-mannitol

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 80 percent / aq. AcOH
2: 1) NaIO4; 2) sodium borohydride
View Scheme
2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: toluene-4-sulfonic acid / methanol; cyclohexane / 0.25 h / 102 °C / Reflux
2: lithium aluminium tetrahydride / tetrahydrofuran / 3 h / 0 - 20 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: toluene-4-sulfonic acid / methanol; cyclohexane / 7 h / 70 °C / Inert atmosphere
2: lithium aluminium tetrahydride / tetrahydrofuran / 16 h / 0 - 23 °C / Inert atmosphere
View Scheme
methanol
67-56-1

methanol

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

Conditions
ConditionsYield
With sodium tetrahydroborate at 20℃; Cooling with ice;64.8 g
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

[(4R,5R)-5-({[tert-butyl(dimethyl)silyl]oxy}methyl)-2,2-dimethyl-1,3-dioxolan-4-yl]methanol
145554-06-9

[(4R,5R)-5-({[tert-butyl(dimethyl)silyl]oxy}methyl)-2,2-dimethyl-1,3-dioxolan-4-yl]methanol

Conditions
ConditionsYield
Stage #1: (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol With sodium hydride In tetrahydrofuran; mineral oil at 5℃; for 0.75h; Inert atmosphere;
Stage #2: tert-butyldimethylsilyl chloride In tetrahydrofuran; mineral oil at 20℃; for 16h; Inert atmosphere;
98%
Stage #1: (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol With sodium hydride In 1,2-dimethoxyethane at 0℃; for 0.5h;
Stage #2: tert-butyldimethylsilyl chloride In 1,2-dimethoxyethane at 0 - 20℃;
97%
With sodium hydride In 1,2-dimethoxyethane at 0 - 20℃;97%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

tert-butylchlorodiphenylsilane
58479-61-1

tert-butylchlorodiphenylsilane

(4R,5R)-trans-2,2-dimethyl-4-tert-butyldiphenylsiloxymethyl-5-hydroxymethyl-1,3-dioxolane
169871-36-7

(4R,5R)-trans-2,2-dimethyl-4-tert-butyldiphenylsiloxymethyl-5-hydroxymethyl-1,3-dioxolane

Conditions
ConditionsYield
Stage #1: (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 1h; Inert atmosphere;
Stage #2: tert-butylchlorodiphenylsilane In tetrahydrofuran; mineral oil at 0℃; for 16h; Inert atmosphere;
96%
With sodium hydride 1.) THF, 45 min, RT, 2.) THF, 45 min; Yield given. Multistep reaction;
With sodium hydride In tetrahydrofuran
With sodium hydride
triisopropylsilyl chloride
13154-24-0

triisopropylsilyl chloride

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

(2R,3R)-4-<(triisopropylsilyl)oxy>-2,3-(isopropylidenedioxy)butanol
221154-50-3

(2R,3R)-4-<(triisopropylsilyl)oxy>-2,3-(isopropylidenedioxy)butanol

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran at 0℃; for 3h;96%
With sodium hydride In tetrahydrofuran at 20℃; for 3h;94%
With sodium hydride In tetrahydrofuran at 0 - 20℃;90%
With sodium hydride In tetrahydrofuran88%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

allyl bromide
106-95-6

allyl bromide

(4R,5R)-bis[(allyloxy)methyl]-2,2-dimethyl-1,3-dioxolane
783339-91-3

(4R,5R)-bis[(allyloxy)methyl]-2,2-dimethyl-1,3-dioxolane

Conditions
ConditionsYield
Stage #1: (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol With sodium hydride In N,N-dimethyl-formamide at 0℃; for 0.25h;
Stage #2: allyl bromide In N,N-dimethyl-formamide at 20℃; for 2h;
96%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

benzyl bromide
100-39-0

benzyl bromide

1,4-di-O-benzyl-2,3-O-isopropylidene-D-threitol
91604-40-9

1,4-di-O-benzyl-2,3-O-isopropylidene-D-threitol

Conditions
ConditionsYield
Stage #1: (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol With sodium hydride In tetrahydrofuran at 20 - 80℃; for 2h;
Stage #2: benzyl bromide In tetrahydrofuran at 80℃; for 24h;
95%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

10-bromo-5,15-diphenylporphyrin

10-bromo-5,15-diphenylporphyrin

C71H54N8O4

C71H54N8O4

Conditions
ConditionsYield
With caesium carbonate; bis[2-(diphenylphosphino)phenyl] ether; tris-(dibenzylideneacetone)dipalladium(0) In toluene at 100℃; for 36h;95%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

p-methoxybenzyl chloride
824-94-2

p-methoxybenzyl chloride

C23H30O6

C23H30O6

Conditions
ConditionsYield
With tetra-(n-butyl)ammonium iodide; sodium hydride In N,N-dimethyl-formamide at 20℃; for 3h;93%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

1,4-di-o-tosyl-2,3-isopropylidene-D-threitol
51064-65-4

1,4-di-o-tosyl-2,3-isopropylidene-D-threitol

Conditions
ConditionsYield
With pyridine at -15℃;91%
With triethylamine In diethyl ether at 30℃; for 17h;85%
With triethylamine In tert-butyl methyl ether85%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

(4R,5R)-<5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolane-4-yl>methyl p-toluenesulfonate
73711-65-6

(4R,5R)-<5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolane-4-yl>methyl p-toluenesulfonate

Conditions
ConditionsYield
With sodium hydroxide; tetra(n-butyl)ammonium hydrogensulfate In dichloromethane; water at 20℃; for 2h; Inert atmosphere;91%
With n-butyllithium89%
With tetra(n-butyl)ammonium hydrogensulfate; sodium hydroxide In dichloromethane; water at 0 - 20℃; for 1h;73.3%
With n-butyllithium DMSO, THF, 1) r.t., 15 min, 2) r.t., 1 h; Yield given. Multistep reaction;
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

6-benzyloxyhexyl 4-methylbenzenesulfonate
126519-80-0

6-benzyloxyhexyl 4-methylbenzenesulfonate

1,4-bis-O-(6-benzyloxyhexyl)-2,3-O-isopropylidene-D-threitol
866429-85-8

1,4-bis-O-(6-benzyloxyhexyl)-2,3-O-isopropylidene-D-threitol

Conditions
ConditionsYield
Stage #1: (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol With sodium hydride In tetrahydrofuran at 20 - 80℃; for 2h;
Stage #2: 6-benzyloxyhexyl 4-methylbenzenesulfonate In tetrahydrofuran at 80℃; for 72h;
91%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

benzyl bromide
100-39-0

benzyl bromide

1-O-benzyl-2,3-O-isopropylidene-D-threitol
78469-77-9

1-O-benzyl-2,3-O-isopropylidene-D-threitol

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 2h; from -50 deg C to 0 deg C;89%
With sodium hydride In N,N-dimethyl-formamide88%
With sodium hydride In N,N-dimethyl-formamide 1.) -15 deg C, 30 min, 2.) -15 deg C, 0.5 h; r.t. 1 h;86%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

benzyl chloride
100-44-7

benzyl chloride

1-O-benzyl-2,3-O-isopropylidene-D-threitol
78469-77-9

1-O-benzyl-2,3-O-isopropylidene-D-threitol

Conditions
ConditionsYield
Stage #1: (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol With sodium hydride In N,N-dimethyl-formamide at -15℃; for 0.5h;
Stage #2: benzyl chloride In N,N-dimethyl-formamide at 20℃; for 1h;
88%
With sodium hydroxide; tetrabutylammomium bromide In dichloromethane at 50℃; for 14h;74%
With sodium hydroxide 1.) DMSO, RT, 1 h, 2.) DMSO, 12 h; Yield given; Multistep reaction;
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

3,4-dihydroxythiophene-2,5-dicarboxylic acid diethyl ester
1822-66-8

3,4-dihydroxythiophene-2,5-dicarboxylic acid diethyl ester

C17H22O8S
1311140-79-0

C17H22O8S

Conditions
ConditionsYield
With tributylphosphine; diamide In tetrahydrofuran at 60℃; Mitsunobu reaction; Darkness; Inert atmosphere;86%
With tributylphosphine; diamide In tetrahydrofuran at 60℃; for 36h; Mitsunobu reaction;78%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

p-methoxybenzyl chloride
824-94-2

p-methoxybenzyl chloride

((4R,5R)-5-(((4-methoxybenzyl)oxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)methanol
118620-86-3

((4R,5R)-5-(((4-methoxybenzyl)oxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)methanol

Conditions
ConditionsYield
With 85percent KOH In benzene for 9h; Heating;83%
With potassium hydroxide In benzene for 9h; Inert atmosphere; Reflux;82%
Stage #1: (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol With sodium hydride In tetrahydrofuran at 0 - 23℃; for 1h; Inert atmosphere;
Stage #2: p-methoxybenzyl chloride In tetrahydrofuran at 23℃; Inert atmosphere;
78%
Stage #1: (4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol With sodium hydride In tetrahydrofuran; N,N-dimethyl-formamide at 0℃; for 1.5h;
Stage #2: p-methoxybenzyl chloride In tetrahydrofuran; N,N-dimethyl-formamide at 0 - 20℃; for 18h;
74%
With potassium hydroxide In benzene for 4h; Heating;73%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

threitol
2319-57-5

threitol

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In dichloromethane at 20℃; for 2h;83%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

2,3-O-isopropylidene-1,4-di-O-methanesulphonyl-D-threitol
109281-59-6

2,3-O-isopropylidene-1,4-di-O-methanesulphonyl-D-threitol

Conditions
ConditionsYield
With pyridine In dichloromethane82%
With pyridine66%
With pyridine
With triethylamine In dichloromethane at 0℃; for 1h; Inert atmosphere;
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

benzyl chloride
100-44-7

benzyl chloride

1,4-di-O-benzyl-2,3-O-isopropylidene-D-threitol
91604-40-9

1,4-di-O-benzyl-2,3-O-isopropylidene-D-threitol

Conditions
ConditionsYield
With paraffine; sodium hydride In tetrahydrofuran 1.) 16 h, RT, 2.) 2 h, reflux;81%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

ethyl chlorocarbonylacetate
36239-09-5

ethyl chlorocarbonylacetate

Malonic acid (4R,5R)-5-(2-ethoxycarbonyl-acetoxymethyl)-2,2-dimethyl-[1,3]dioxolan-4-ylmethyl ester ethyl ester
200133-32-0

Malonic acid (4R,5R)-5-(2-ethoxycarbonyl-acetoxymethyl)-2,2-dimethyl-[1,3]dioxolan-4-ylmethyl ester ethyl ester

Conditions
ConditionsYield
With pyridine In dichloromethane for 5h; Ambient temperature;81%
With pyridine In dichloromethane Yield given;
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

methyl (triphenylphosphoranylidene)acetate
21204-67-1

methyl (triphenylphosphoranylidene)acetate

(Z)-(4R,5R)-3-(5-hydroxymethyl-2,2-dimethyl[1,3]dioxolan-4-yl)acrylic acid methyl ester
109613-69-6

(Z)-(4R,5R)-3-(5-hydroxymethyl-2,2-dimethyl[1,3]dioxolan-4-yl)acrylic acid methyl ester

Conditions
ConditionsYield
With manganese(IV) oxide In dichloromethane at 20℃; for 24h; stereoselective reaction;80%
(3aS)-1-chloro-2-phenyl-hexahydro-1H-pyrrolo[1,2-c][1,3,2]diazaphosphole

(3aS)-1-chloro-2-phenyl-hexahydro-1H-pyrrolo[1,2-c][1,3,2]diazaphosphole

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

(4R,5R)-4,5-bis[((2R,5S)-3-phenyl-1,3-diaza-2-phosphabicyclo[3.3.0]octyloxy)methyl]-2,2-dimethyl-1,3-dioxolane

(4R,5R)-4,5-bis[((2R,5S)-3-phenyl-1,3-diaza-2-phosphabicyclo[3.3.0]octyloxy)methyl]-2,2-dimethyl-1,3-dioxolane

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 20 - 45℃; for 24.5h; Inert atmosphere; stereoselective reaction;80%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

benzyl bromide
100-39-0

benzyl bromide

(4S,5S)-4-benzyloxymethyl-5-hydroxymethyl-2,2-dimethyl-1,3-dioxolane
78469-77-9, 81076-11-1, 128820-40-6, 78513-03-8

(4S,5S)-4-benzyloxymethyl-5-hydroxymethyl-2,2-dimethyl-1,3-dioxolane

Conditions
ConditionsYield
With silver(l) oxide In toluene at 20℃; for 8h; Inert atmosphere;77%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

ethyl chlorocarbonylacetate
36239-09-5

ethyl chlorocarbonylacetate

C12H20O7
1433901-15-5

C12H20O7

Conditions
ConditionsYield
With pyridine In tetrahydrofuran at 0 - 20℃; Inert atmosphere;77%
(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

propargyl bromide
106-96-7

propargyl bromide

C13H18O4

C13H18O4

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 1h;71%
triethylsilyl chloride
994-30-9

triethylsilyl chloride

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol
73346-74-4

(4R,5R)-2,2-dimethyl-1,3-dioxolane-4,5-dimethanol

((4R,5R)-2,2-Dimethyl-5-(triethylsilyloxymethyl)-1,3-dioxolan-4-yl)methanol

((4R,5R)-2,2-Dimethyl-5-(triethylsilyloxymethyl)-1,3-dioxolan-4-yl)methanol

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran; mineral oil at 0 - 20℃; for 3h; Inert atmosphere;70%

73346-74-4Relevant academic research and scientific papers

Combination of chemotherapy and oxidative stress to enhance cancer cell apoptosis

Fang, Jianguo,Hou, Yanan,Li, Jin,Li, Xinming,Wang, Song,Zhao, Jintao

, p. 3215 - 3222 (2020/04/08)

Cancer cells are vulnerable to reactive oxygen species (ROS) due to their abnormal redox environment. Accordingly, combination of chemotherapy and oxidative stress has gained increasing interest for the treatment of cancer. We report a novel seleno-prodrug of gemcitabine (Gem), Se-Gem, and evaluated its activation and biological effects in cancer cells. Se-Gem was prepared by introducing a 1,2-diselenolane (a five-membered cyclic diselenide) moiety into the parent drug Gemvia a carbamate linker. Se-Gem is preferably activated by glutathione (GSH) and displays a remarkably higher potency than Gem (up to a 6-fold increase) to a panel of cancer cell lines. The activation of Se-Gem by GSH releases Gem and a seleno-intermediate nearly quantitatively. Unlike the most ignored side products in prodrug activation, the seleno-intermediate further catalyzes a conversion of GSH and oxygen to GSSG (oxidized GSH) and ROS via redox cycling reactions. Thus Se-Gem may be considered as a suicide agent to deplete GSH and works by a combination of chemotherapy and oxidative stress. This is the first case that employs a cyclic diselenide in prodrug design, and the success of Se-Gem as well as its well-defined action mechanism demonstrates that the 1,2-diselenolane moiety may serve as a general scaffold to advance constructing novel therapeutic molecules with improved potency via a combination of chemotherapy and oxidative stress.

Novel protection of 1,2-diol for trans-dihydroxycyclopentene ring construction by the C[sbnd]H insertion of alkylidene carbene: Formal total synthesis of (+)-trehazolin

Ohira, Susumu,Kuboki, Atsuhito,Takimoto, Yoshimi,Matsuda, Kyosuke,Itasaki, Saori,Urushibata, Yuki,Takano, Yoshiyuki,Nakamura, Yuuki

, (2019/09/03)

The chiral vicinal diol was protected as 6-methylene-1,4-dioxepane to construct a cyclopentene ring by the C[sbnd]H insertion of alkylidene carbene. The removal of the protecting group was achieved in a few steps, affording the corresponding diol in a reasonable yield. Using these reactions, the known synthetic intermediate for (+)-trehazolin was synthesized from D-diethyl tartrate. In addition, a short route to the intermediate from a D-mannitol derivative was described.

Supramolecular gels from sugar-linked triazole amphiphiles for drug entrapment and release for topical application

Sharma, Komal,Joseph, Jojo P.,Sahu, Adarsh,Yadav, Narender,Tyagi, Mohit,Singh, Ashmeet,Pal, Asish,Kartha, K.P. Ravindranathan

, p. 19819 - 19827 (2019/07/05)

A simple molecular framework obtained by cross-linking a hydrophobic chain with S,S- and R,R-tetritol by the copper-catalysed azide-alkyne cycloaddition reaction is found to serve as an excellent bioisostere for self-assembly. The hexadecyl-linked triazolyl tetritol composite spontaneously self-assembles in n-hepane and methanol to form hierarchical organogels. Microscopic analyses and X-ray diffraction studies demonstrate eventual formation of nanotubes through lamellar assembly of the amphiphiles. A rheological investigation shows solvent-dictated mechanical properties that obey power law behavior similar to other low molecular weight gelators (LMOGs). The gel network was then utilized for the entrapment of drugs e.g. ibuprofen and 5-fluorouracil, with tunable mechanical behaviour under applied stress. The differential release profiles of the drugs over a period of a few hours as a result of the relative spatio-temporal location in the supramolecular network can be utilized for topical formulations.

Stereoselective synthesis of the lichen metabolite, (+) montagnetol and its congeners as antimicrobial agents

Mallavadhani, Uppuluri Venkata,Boddu, Ramakrishna,Rathod, Balaji B.,Reddy Setty, Prakasam

supporting information, p. 2992 - 2999 (2018/10/15)

In view of structural diversity, (+) montagnetol, the major metabolite of the fruticose lichen, Roccella montagnei was synthesized along with three of its congeners by employing highly efficient protocols. (+) Montagnetol (2 R, 3S; 11) and (-) montagnetol (2S, 3R; 5) were synthesized in 7 and 9 steps, respectively, from L-ascorbic acid. The two new congeners 3 (2 R, 3R) and 6 (2S, 3S), which differ in configuration at C-2 and C-3 positions of the (+) montagnetol, were synthesized from (?) diethyl D-tartrate and (+) diethyl L-tartrate, respectively. The synthesized compounds were evaluated in vitro for antimicrobial activity against two Gram-positive (S. aureus and E. coli) and two Gram-negative (S. typhi and P. aeruginosa) bacteria and one fungal strain Candida albicans. Interestingly, the congener 3 showed promising anti-bacterial activity (MIC: 0.062 μg/ml) against P. aeruginosa, whereas the congener 6 displayed potent anti-fungal activity (MIC: 0.062 μg/ml) against C. Albicans.

CYCLIC COMPOUND

-

Paragraph 0320, (2018/04/13)

The present invention provides compounds having a Toll-like receptor 4 (TLR4) signaling inhibitory action useful as preventive and therapeutic drugs of autoimmune disease and/or inflammatory disease or diseases such as chemotherapy-induced peripheral neuropathy (CIPN), chemotherapy-induced neuropathic pain (CINP), liver injury, ischemia-reperfusion injury (IRI) and the like. The present invention relates to a compound represented by formula (I) and a salt thereof: (wherein, each symbol is explained in greater detail in the specification).

Stereocontrolled synthesis of four isomeric linoleate triols of relevance to skin barrier formation and function

Davis, Robert W.,Allweil, Alexander,Tian, Jianhua,Brash, Alan R.,Sulikowski, Gary A.

, p. 4571 - 4573 (2018/11/23)

Linoleate triol esters are intermediates along the pathway of formation of the mammalian skin permeability barrier. In connection with the study of their involvement in barrier formation we required access to isomerically pure and defined samples of four linoleate triol esters. A common synthetic strategy was developed starting from isomeric alkynols derived from D-tartaric acid and 2-deoxy-D-ribose.

Chiroptical properties of 2,2’-bioxirane

Daugey,De Rycke,Brotin,Buffeteau

supporting information, p. 342 - 350 (2018/01/15)

The two enantiomers of 2,2′-bioxirane were synthesized, and their chiroptical properties were thoroughly investigated in various solvents by polarimetry, vibrational circular dichroism (VCD), and Raman optical activity (ROA). Density functional theory (DFT) calculations at the B3LYP/aug-cc-pVTZ level revealed the presence of three conformers (G+, G?, and cis) with Gibbs populations of 51, 44, and 5% for the isolated molecule, respectively. The population ratios of the two main conformers were modified for solvents exhibiting higher dielectric constants (G? form decreases whereas G+ form increases). The behavior of the specific optical rotation values with the different solvents was correctly reproduced by time-dependent DFT calculations using the polarizable continuum model (PCM), except for the benzene for which explicit solvent model should be necessary. Finally, VCD and ROA spectra were perfectly reproduced by the DFT/PCM calculations for the Boltzmann-averaged G+ and G? conformers.

Hydrogen Bonding-Assisted Enhancement of the Reaction Rate and Selectivity in the Kinetic Resolution of d,l-1,2-Diols with Chiral Nucleophilic Catalysts

Fujii, Kazuki,Mitsudo, Koichi,Mandai, Hiroki,Suga, Seiji

supporting information, p. 2778 - 2788 (2017/08/23)

An extremely efficient acylative kinetic resolution of d,l-1,2-diols in the presence of only 0.5 mol% of binaphthyl-based chiral N,N-4-dimethylaminopyridine was developed (selectivity factor of up to 180). Several key experiments revealed that hydrogen bonding between the tert-alcohol unit(s) of the catalyst and the 1,2-diol unit of the substrate is critical for accelerating the rate of monoacylation and achieving high enantioselectivity. This catalytic system can be applied to a wide range of substrates involving racemic acyclic and cyclic 1,2-diols with high selectivity factors. The kinetic resolution of d,l-hydrobenzoin and trans-1,2-cyclohexanediol on a multigram scale (10 g) also proceeded with high selectivity and under moderate reaction conditions: (i) very low catalyst loading (0.1 mol%); (ii) an easily achievable low reaction temperature (0 °C); (iii) high substrate concentration (1.0 M); and (iv) short reaction time (30 min). (Figure presented.).

Formal Total Synthesis of Amphidinolide e

Bosch, Lluís,Mola, Laura,Petit, Elena,Saladrigas, Mar,Esteban, Jorge,Costa, Anna M.,Vilarrasa, Jaume

, p. 11021 - 11034 (2017/10/27)

A formal total synthesis of the cytotoxic macrolide amphidinolide E is reported. The strategic steps are three Julia-Kocienski reactions (J-K), for the formation of the C5-C6, C9-C10, and C17-C18 double bonds, a Suzuki-Molander C21-C22 bond formation reaction, and a Kita-Trost macrolactonization. The "instability" of the two dienic systems and of the stereocenter at C2 (allylic methine, α to the carboxy group) and the protecting groups at C17-OH and C18-OH have posed difficult challenges. Each Julia-Kocienski olefination has been systematically optimized to provide the highest possible E/Z ratios.

Stereoselective Synthesis of the C27-C35 Eribulin Fragment and Its Utilization in Building Structurally Diverse Macrocycles

Konda, Saidulu,Khatravath, Mahender,Mallurwar, Naveen Kumar,Rao, Pallavi,Sripelly, Shivashankar,Iqbal, Javed,Arya, Prabhat

, p. 1663 - 1683 (2016/05/24)

A practical and scalable stereoselective synthesis of the western substituted tetrahydrofuran ring C27-C35 fragment of eribulin was developed by using (2S,3S)-tartaric acid as a cheap starting material that was converted into an intermediate through a stereoselective vinylation and cross-metathesis as the key steps. A regio-and stero-selective intramolecular oxy-Michael cyclization or an iodocyclization reaction finally provided the required western tetrahydrofuran ring fragment and its related isomeric analogues. These key fragments were further utilized in obtaining several types of macrocyclic derivatives for exploration of their biological properties. The simplicity of our present approach has the potential to be considered for large-scale syntheses of key fragments of eribulin and related analogues.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 73346-74-4